Heron Therapeutics
HRTX
#10092
Rank
ยฃ52.38 M
Marketcap
ยฃ0.28
Share price
26.48%
Change (1 day)
-67.33%
Change (1 year)

EPS for Heron Therapeutics (HRTX)

EPS in 2023 (TTM): -ยฃ0.98

According to Heron Therapeutics's latest financial reports the company's current EPS (TTM) is -ยฃ0.14. In 2022 the company made an earnings per share (EPS) of -ยฃ1.29 an increase over its 2021 EPS that were of -ยฃ1.68.

EPS history for Heron Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-ยฃ0.98-24.22%
2022-ยฃ1.29-23.11%
2021-ยฃ1.68-10%
2020-ยฃ1.86-0%
2019-ยฃ1.861.21%
2018-ยฃ1.84-32.7%
2017-ยฃ2.73-19.34%
2016-ยฃ3.3954.76%
2015-ยฃ2.191.73%
2014-ยฃ2.15-16.23%
2013-ยฃ2.5791.67%
2012-ยฃ1.34-31.45%
2011-ยฃ1.96-27.06%
2010-ยฃ2.68-43.75%
2009-ยฃ4.76-57.33%
2008-ยฃ11.17-82.92%
2007-ยฃ65.3720.61%
2006-ยฃ54.20175.76%
2005-ยฃ19.66-21.43%
2004-ยฃ25.02100%
2003-ยฃ12.51-38.24%
2002-ยฃ20.25161.54%
2001-ยฃ7.74-106.46%
2000ยฃ119.792051.55%
1999ยฃ5.57839.73%
1998ยฃ0.59-105.48%
1997-ยฃ10.82-88.16%
1996-ยฃ91.38

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
SurModics
SRDX
-ยฃ0.92 547.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Pacira Biosciences
PCRX
ยฃ0.26-284.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
ยฃ7.45-5,368.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
ยฃ0.30-310.53%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Nektar Therapeutics
NKTR
-ยฃ2.20 1,457.89%๐Ÿ‡บ๐Ÿ‡ธ USA